Clinical studies recruiting near Hamburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · Hope Hamburg · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Universitaetsklinikum Hamburg-Eppendorf · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University Medical Center Hamburg · Joseph Broderick, MD · NCT07227246 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Universitaetsklinikum Hamburg-Eppendorf · Pfizer · NCT07028853 Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Phase N/A · University Medical Center Hamburg-Eppendorf, Department of P · Insel Gruppe AG, University Hospital Bern · NCT01257269 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · University Medical Center Hamburg-Eppendorf · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Universitaetsklinikum Hamburg-Eppendorf · Bristol-Myers Squibb · NCT07106762 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · University Medical Center Hamburg-Eppendorf · Miltenyi Biomedicine GmbH · NCT04844866 Network Properties As Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke
NA · University Medical Center Hamburg-Eppendorf, Dept. of Neurol · Universitätsklinikum Hamburg-Eppendorf · NCT05560724 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Albertinen Krankenhaus · AGO Study Group · NCT05009082 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Universitätsklinikum Hamburg, Eppendorf · Boehringer Ingelheim · NCT07355296 REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Abteilung für Radiologie, Neuroradiologie und Nuklearmedizin · Acandis GmbH · NCT05345483 A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Phase 4 · University Medical Center Hamburg-Eppendorf · Peter Rossing · NCT07239570 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH - Hambur · Takeda · NCT06671496 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Universitätsklinikum Hamburg-Eppendorf · Travere Therapeutics, Inc. · NCT06247085 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Universitätsklinikum Hamburg-Eppendorf · Hoffmann-La Roche · NCT06793215 A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During P
Phase N/A · Universitaetsklinikum Hamburg Eppendorf · BioMarin Pharmaceutical · NCT05579548 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Universitaetsklinikum Hamburg-Eppendorf · Amgen · NCT07037433 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Misma
Phase 2 · Hamburg Hämatologisch-Onkologische Praxis Eppendorf-Facharzt · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06856837 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Universitaet Hamburg - Institut fuer Biochemie und Molekular · Ipsen · NCT07435428 A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · Universitätsklinikum Eppendorf · Deciphera Pharmaceuticals, LLC · NCT05957367 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 Endometrial Cancer Lymphadenectomy Trial
NA · Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklini · Philipps University Marburg · NCT03438474 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Kardiologie am Tibarg · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615

Look up another city

Look up another condition